Cargando…
Isotype-specific inhibition of the phosphatidylinositol-3-kinase pathway in hematologic malignancies
In the last decade, the advent of biological targeted therapies has revolutionized the management of several types of cancer, especially in the realm of hematologic malignancies. One of these pathways, and the center of this review, is the phosphatidylinositol-3-kinase (PI3K) pathway. The PI3K pathw...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937185/ https://www.ncbi.nlm.nih.gov/pubmed/24591840 http://dx.doi.org/10.2147/OTT.S34641 |